{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:42:43Z","timestamp":1772131363269,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ygyno.2022.08.022","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T23:26:31Z","timestamp":1662593191000},"page":"269-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Peroperative extent of peritoneal metastases affects the surgical outcome and survival in advanced ovarian cancer"],"prefix":"10.1016","volume":"167","author":[{"given":"R.M.","family":"van Stein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"Engbersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Stolk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lopez-Yurda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Lahaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.G.H.","family":"Beets-Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.A.R.","family":"Lok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.S.","family":"Sonke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.J.","family":"Van Driel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ygyno.2022.08.022_bb0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"10.1016\/j.ygyno.2022.08.022_bb0010","first-page":"937","article-title":"Diagnosis and management of ovarian cancer","volume":"93","author":"Doubeni","year":"2016","journal-title":"Am. Fam. Physician"},{"issue":"5","key":"10.1016\/j.ygyno.2022.08.022_bb0015","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2022.08.022_bb0020","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/IGC.0b013e31823de6ae","article-title":"Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD data","volume":"22","author":"Polterauer","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2022.08.022_bb0025","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2022.08.022_bb0030","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/464123","article-title":"Prognostic value of residual disease after interval Debulking surgery for FIGO stage IIIC and IV epithelial ovarian cancer","volume":"2015","author":"Rutten","year":"2015","journal-title":"Obstet. Gynecol. Int."},{"issue":"2","key":"10.1016\/j.ygyno.2022.08.022_bb0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ygyno.2017.11.018","article-title":"Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology\/Gynecologic Oncology Group ancillary data study","volume":"148","author":"Hamilton","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2022.08.022_bb0040","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"28","key":"10.1016\/j.ygyno.2022.08.022_bb0045","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1200\/JCO.2016.68.6907","article-title":"Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: society of gynecologic oncology and American society of clinical oncology clinical practice guideline","volume":"34","author":"Wright","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2022.08.022_bb0050","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1136\/ijgc-2020-001640","article-title":"Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)","volume":"30","author":"Fagotti","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2022.08.022_bb0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ygyno.2005.07.123","article-title":"Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon","volume":"100","author":"Aletti","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.08.022_bb0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ygyno.2014.11.004","article-title":"Nomogram for predicting incomplete cytoreduction in advanced ovarian cancer patients","volume":"136","author":"Shim","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"24","key":"10.1016\/j.ygyno.2022.08.022_bb0065","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","article-title":"Prognostic factors for stage III epithelial ovarian cancer: a gynecologic oncology group study","volume":"25","author":"Winter","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2022.08.022_bb0070","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.ygyno.2022.08.022_bb0075","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ygyno.2022.08.022_bb0080","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ejso.2009.02.010","article-title":"Quantitative intra-operative assessment of peritoneal carcinomatosis - a comparison of three prognostic tools","volume":"35","author":"Swellengrebel","year":"2009","journal-title":"Eur. J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2022.08.022_bb0085","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/bjs.4516","article-title":"Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy","volume":"91","author":"Verwaal","year":"2004","journal-title":"Br. J. Surg."},{"issue":"2","key":"10.1016\/j.ygyno.2022.08.022_bb0090","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ygyno.2008.07.035","article-title":"CA125 decline in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy","volume":"111","author":"Richardson","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2022.08.022_bb0095","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1158\/1055-9965.EPI-18-0203","article-title":"Chronic medical conditions and CA125 levels among women without ovarian cancer","volume":"27","author":"Akinwunmi","year":"2018","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"8","key":"10.1016\/j.ygyno.2022.08.022_bb0100","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s11547-020-01170-6","article-title":"Radiological assessment of peritoneal cancer index on preoperative CT in ovarian cancer is related to surgical outcome and survival","volume":"125","author":"Avesani","year":"2020","journal-title":"Radiol. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2022.08.022_bb0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ygyno.2015.11.022","article-title":"Prediction of incomplete primary debulking surgery in patients with advanced ovarian cancer: An external validation study of three models using computed tomography","volume":"140","author":"Rutten","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2022.08.022_bb0110","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/IGC.0000000000000368","article-title":"Predicting surgical outcome in patients with International Federation of Gynecology and Obstetrics stage III or IV ovarian cancer using computed tomography: a systematic review of prediction models","volume":"25","author":"Rutten","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2022.08.022_bb0115","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejca.2017.06.010","article-title":"Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer","volume":"83","author":"Michielsen","year":"2017","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2022.08.022_bb0120","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/0284185116658683","article-title":"Preoperative prediction of suboptimal resection in advanced ovarian cancer based on clinical and CT parameters","volume":"58","author":"Son","year":"2016","journal-title":"Acta Radiol."},{"issue":"7","key":"10.1016\/j.ygyno.2022.08.022_bb0125","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.acra.2019.09.019","article-title":"The value of contrast-enhanced CT in the detection of residual disease after neo-adjuvant chemotherapy in ovarian cancer","volume":"27","author":"An","year":"2020","journal-title":"Acad. Radiol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.08.022_bb0130","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ygyno.2021.01.013","article-title":"A prospective study on the diagnostic pathway of patients with stage IIIC-IV ovarian cancer: exploratory laparoscopy (EXL) + CT scan VS. CT scan","volume":"161","author":"Tozzi","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2022.08.022_bb0135","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1200\/JCO.2016.69.2962","article-title":"Laparoscopy to predict the result of primary cytoreductive surgery in patients with advanced ovarian cancer: a randomized controlled trial","volume":"35","author":"Rutten","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2022.08.022_bb0140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejogrb.2016.10.034","article-title":"Imaging diagnostics in ovarian cancer: magnetic resonance imaging and a scoring system guiding choice of primary treatment","volume":"210","author":"Kasper","year":"2017","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ygyno.2022.08.022_bb0145","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejrad.2019.03.007","article-title":"MRI with diffusion-weighted imaging to predict feasibility of complete cytoreduction with the peritoneal cancer index (PCI) in advanced stage ovarian cancer patients","volume":"114","author":"Engbersen","year":"2019","journal-title":"Eur. J. Radiol."},{"issue":"8","key":"10.1016\/j.ygyno.2022.08.022_bb0150","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1200\/JCO.2014.56.3106","article-title":"Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182","volume":"33","author":"Horowitz","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.08.022_bb0155","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejso.2017.11.003","article-title":"Prognostic value of peritoneal cancer index in primary advanced ovarian cancer","volume":"44","author":"Llueca","year":"2018","journal-title":"Eur. J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.08.022_bb0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/ejso.2002.1380","article-title":"Peritoneal cancer index: a prognostic indicator of survival in advanced ovarian cancer","volume":"29","author":"Tentes","year":"2003","journal-title":"Eur. J. Surg. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2022.08.022_bb0165","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1245\/s10434-014-4329-7","article-title":"Prognostic and predictive value of the peritoneal cancer index in primary advanced epithelial ovarian cancer patients after complete cytoreductive surgery: study of tumor bank ovarian cancer","volume":"22","author":"Gasimli","year":"2015","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.08.022_bb0170","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0090-8258(03)00278-6","article-title":"Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study","volume":"90","author":"Eisenkop","year":"2003","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.08.022_bb0180","first-page":"27","article-title":"Lighting the way for improved detection of ovarian cancer","volume":"327","author":"Voelker","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ygyno.2022.08.022_bb0185","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejso.2020.10.012","article-title":"Distribution of residual disease in the peritoneum following neoadjuvant chemotherapy in advanced epithelial ovarian cancer and its potential therapeutic implications","volume":"47","author":"Bhatt","year":"2021","journal-title":"Eur. J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.08.022_bb0190","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1245\/s10434-020-08918-4","article-title":"Total parietal peritonectomy can be performed with acceptable morbidity for patients with advanced ovarian cancer after neoadjuvant chemotherapy: results from a prospective multi-centric study","volume":"28","author":"Bhatt","year":"2021","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.08.022_bb0195","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1245\/s10434-020-08649-6","article-title":"The peritoneal cancer index is a strong predictor of incomplete cytoreductive surgery in ovarian cancer","volume":"28","author":"J\u00f3nsd\u00f3ttir","year":"2021","journal-title":"Ann. Surg. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2022.08.022_bb0200","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.ejso.2021.03.233","article-title":"Peroperative scoring systems for predicting the outcome of cytoreductive surgery in advanced-stage ovarian cancer - a systematic review","volume":"47","author":"Engbersen","year":"2021","journal-title":"Eur. J. Surg. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822005765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822005765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:03:16Z","timestamp":1758772996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825822005765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0090825822005765"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.08.022","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peroperative extent of peritoneal metastases affects the surgical outcome and survival in advanced ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}